Capital Flow Monitor · Sponsors · CIK 2066192
Character Biosciences, Inc.
3 2nd Street, Suite 302, JERSEY CITY, NJ, 07311-4056 · (929) 310-5933
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$19.6M
Sold
$8.9M
% sold
45.1%
Investors
4
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-17 | D ·current | 506(b) | $19.6M | $8.9M | 45.1% | 4 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Cheng Zhang — Executive Officer / Director, Jersey City, NJ
-
Nick Olsen — Director, Jersey City, NJ
1 other raise
- Averna Therapeutics Inc. $85.0M of $85.0M · 100.0%
-
Vivek Garipalli — Director, Jersey City, NJ
1 other raise
- Thyme Care, Inc. $97.0M of $100.0M · 97.0%
- Peter DiLaura — Director, Jersey City, NJ
-
Reut Shema — Director, Jersey City, NJ
1 other raise
- aMoon Edge Limited Partnership $42.6M of —
- James Kasuboski — Director, Jersey City, NJ
- Mayssa Attar — Director, Jersey City, NJ
-
Jason Hafler — Director, Jersey City, NJ
1 other raise
- Star Therapeutics LLC $125.0M of $125.0M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.